摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-methoxy-3-(3-methoxypropoxy)benzyl)-3-methylbutanal | 1073553-78-2

中文名称
——
中文别名
——
英文名称
2-(4-methoxy-3-(3-methoxypropoxy)benzyl)-3-methylbutanal
英文别名
2-(3-(3-methoxypropoxy)-4-methoxybenzyl)-3-methylbutanal;2-(3-(Methoxypropoxy)-4-methoxybenzyl)-3-methylbutanal;2-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-3-methylbutanal
2-(4-methoxy-3-(3-methoxypropoxy)benzyl)-3-methylbutanal化学式
CAS
1073553-78-2
化学式
C17H26O4
mdl
——
分子量
294.391
InChiKey
JRMIZBDFAFMKRV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    21
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(4-methoxy-3-(3-methoxypropoxy)benzyl)-3-methylbutanal(S)-(+)-1-(Alpha-氨基苄基)-2-萘酚甲醇 为溶剂, 反应 0.25h, 生成 (1S,3R,S)-3-(1-(4-methoxy-3-(3-methoxypropoxy)phenyl)-3-methylbutan-2-yl)-1-phenyl-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine 、 (1S,3R,R)-3-(1-(4-methoxy-3-(3-methoxypropoxy)phenyl)-3-methylbutan-2-yl)-1-phenyl-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine
    参考文献:
    名称:
    Acid promoted CIDT for the deracemization of dihydrocinnamic aldehydes with Betti's base
    摘要:
    对映体的α-可互变和未功能化的醛通过以下步骤转化为富含对映体的混合物:(i) 与(R)-或(S)-1-(α-氨基苄基)-2-萘酚(Betti碱)反应,转化为二面体异构体的3-取代1-苯基-2,3-二氢-1H-萘并[1,2-e][1,3]氧杂啉;(ii) 促酸的结晶诱导二面体异构体转化(CIDT);(iii) 清洁地切割富集的二面体异构体的二氢-1,3-萘氧杂烯环,易于过滤收集,从而回收富含对映体的醛和手性辅助剂。
    DOI:
    10.1039/c0gc00013b
  • 作为产物:
    描述:
    2-(4-甲氧基-3-(3-甲氧基丙氧基)苄基)-3-甲基丁酸乙酯二异丁基氢化铝 作用下, 以 甲苯 为溶剂, 反应 2.25h, 以74%的产率得到2-(4-methoxy-3-(3-methoxypropoxy)benzyl)-3-methylbutanal
    参考文献:
    名称:
    Acid promoted CIDT for the deracemization of dihydrocinnamic aldehydes with Betti's base
    摘要:
    对映体的α-可互变和未功能化的醛通过以下步骤转化为富含对映体的混合物:(i) 与(R)-或(S)-1-(α-氨基苄基)-2-萘酚(Betti碱)反应,转化为二面体异构体的3-取代1-苯基-2,3-二氢-1H-萘并[1,2-e][1,3]氧杂啉;(ii) 促酸的结晶诱导二面体异构体转化(CIDT);(iii) 清洁地切割富集的二面体异构体的二氢-1,3-萘氧杂烯环,易于过滤收集,从而回收富含对映体的醛和手性辅助剂。
    DOI:
    10.1039/c0gc00013b
点击查看最新优质反应信息

文献信息

  • Process for Producing Aliskiren
    申请人:Taddei Maurizio
    公开号:US20130071899A1
    公开(公告)日:2013-03-21
    A new route of synthesis of the compound Aliskiren of formula (I), used in the treatment of hypertension, is described.
    描述了一种用于治疗高血压的化合物阿利司钠(分子式为(I))的新合成途径。
  • [EN] PREPARATION OF A SATURATED ALDEHYDE<br/>[FR] PRÉPARATION D'UN ALDÉHYDE SATURÉ
    申请人:DSM IP ASSETS BV
    公开号:WO2009007461A1
    公开(公告)日:2009-01-15
    The invention relates to a compound according to Formula (IX) and salts thereof, wherein R1, R2 and R5 are each independently selected from H and hydrocarbon moieties, which hydrocarbon moieties optionally comprise one or more heteroatoms, and which hydrocarbons optionally comprise substituents, or when the compound according to formula (IX) is a salt, R1 and/or R2 may be a cation, R3, and R4 each independently selected from hydrocarbon moieties, which hydrocarbon moieties optionally comprise one or more heteroatoms, and which hydrocarbons optionally comprise substituents, and wherein any two of R1, R2, R3, R4 and R5 are optionally linked together to form a ring structure. The invention further relates to the preparation of such a compound and to the use of such a compound for preparing a pharmaceutical compound, an agrochemical compound, an intermediate for a pharmaceutical compound or an intermediate for an agrochemical compound.
    该发明涉及一种符合式(IX)及其盐的化合物,其中R1、R2和R5分别独立地选择自H和烃基团,该烃基团可选地包含一个或多个杂原子,并且该烃基团可选地包括取代基,或者当符合式(IX)的化合物是盐时,R1和/或R2可能是一个阳离子,R3和R4分别独立地选择自烃基团,该烃基团可选地包含一个或多个杂原子,并且该烃基团可选地包括取代基,且R1、R2、R3、R4和R5中的任意两个可选地连接在一起形成环结构。该发明还涉及制备这种化合物以及使用这种化合物制备药物化合物、农药化合物、药物化合物的中间体或农药化合物的中间体。
  • [EN] ALPHA-SUBSTITUTED a,ß-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION a,ß<br/>[FR] E- OU Z-ALDÉHYDES À INSATURATION ?,?, SUBSTITUÉS EN ALPHA, LEUR UTILISATION ET LEURS PROCÉDÉS DE PRÉPARATION
    申请人:DSM FINE CHEM AUSTRIA GMBH
    公开号:WO2009007462A1
    公开(公告)日:2009-01-15
    This invention relates to novel alpha-substituted α,β-unsaturated E- or Z-aldehydes, or isomer mixture thereof, of the formula (I) in which R1 and R2 may be identical or different and are each H or a hydrocarbon, in which the hydrocarbon may have one or more heteroatoms and R3 and R4 may be identical or different and are each a hydrocarbon, in which the hydrocarbon may have one or more heteroatoms, and R5 may be identical or different and is H or a hydrocarbon, in which the hydrocarbon may have one or more heteroatoms, to the use thereof, and to processes for their preparation. The invention further relates to the preparation of further intermediates for pharmaceuticals and to the preparation of the pharmaceuticals.
    这项发明涉及一种新颖的α-取代α,β-不饱和E-或Z-醛,或其异构体混合物,其化学式为(I),其中R1和R2可能相同也可能不同,分别为H或一个碳氢化合物,其中碳氢化合物可能含有一个或多个杂原子,R3和R4可能相同也可能不同,分别为一个碳氢化合物,其中碳氢化合物可能含有一个或多个杂原子,R5可能相同也可能不同,为H或一个碳氢化合物,其中碳氢化合物可能含有一个或多个杂原子,以及其用途和制备方法。该发明还涉及制备药物的进一步中间体以及药物的制备。
  • PREPARATION OF A SATURATED ALDEHYDE
    申请人:Verzijl Gerardus Karel Maria
    公开号:US20100197972A1
    公开(公告)日:2010-08-05
    The invention relates to a compound according to Formula (IX) and salts thereof, wherein R 1 , R 2 and R 5 are each independently selected from H and hydrocarbon moieties, which hydrocarbon moieties optionally comprise one or more heteroatoms, and which hydrocarbons optionally comprise substituents, or when the compound according to formula (IX) is a salt, R 1 and/or R 2 may be a cation, R 3 , and R 4 each independently selected from hydrocarbon moieties, which hydrocarbon moieties optionally comprise one or more heteroatoms, and which hydrocarbons optionally comprise substituents, and wherein any two of R 1 , R 2 , R 3 , R 4 and R 5 are optionally linked together to form a ring structure. The invention further relates to the preparation of such a compound and to the use of such a compound for preparing a pharmaceutical compound, an agrochemical compound, an intermediate for a pharmaceutical compound or an intermediate for an agrochemical compound.
    本发明涉及一种符合式(IX)及其盐的化合物,其中R1、R2和R5各自独立地选择H和烃基,该烃基可以选择包含一个或多个杂原子,并且这些烃基可以包含取代基,或者当符合式(IX)的化合物是盐时,R1和/或R2可以是阳离子,R3和R4各自独立地选择烃基,该烃基可以选择包含一个或多个杂原子,并且这些烃基可以包含取代基,其中任何两个R1、R2、R3、R4和R5可以选择连接在一起形成环结构。本发明还涉及制备这种化合物以及使用这种化合物制备药物化合物、农药化合物、药物化合物中间体或农药化合物中间体。
  • Alpha-substituted α,β-unsaturated E- or Z-aldehydes, use thereof, and processes for their preparation α,β
    申请人:DSM Fine Chemicals Austria NFG GmbH & Co. KG
    公开号:US08088955B2
    公开(公告)日:2012-01-03
    This invention relates to novel alpha-substituted α,β-unsaturated E- or Z-aldehydes, or isomer mixture thereof, of the formula (I) in which R1 and R2 may be identical or different and are each H or a hydrocarbon, in which the hydrocarbon may have one or more heteroatoms and R3 and R4 may be identical or different and are each a hydrocarbon, in which the hydrocarbon may have one or more heteroatoms, and R5 may be identical or different and is H or a hydrocarbon, in which the hydrocarbon may have one or more heteroatoms, to the use thereof, and to processes for their preparation. The invention further relates to the preparation of further intermediates for pharmaceuticals and to the preparation of the pharmaceuticals.
    本发明涉及新的α-取代的α,β-不饱和E-或Z-醛,或其异构体混合物,其化学式为(I),其中R1和R2可以相同或不同,均为H或碳氢化合物,其中碳氢化合物可以具有一个或多个杂原子,R3和R4可以相同或不同,均为碳氢化合物,其中碳氢化合物可以具有一个或多个杂原子,R5可以相同或不同,为H或碳氢化合物,其中碳氢化合物可以具有一个或多个杂原子,以及其用途和制备过程。本发明还涉及制备药物的进一步中间体的制备和药物的制备。
查看更多